Therapeutics MD press release (NASDAQ:TXMD): FY net loss from continuing operations was $7.7 million, or $0.74 per basic and diluted…
Read More »Therapeutics MD press release (NASDAQ:TXMD): FY net loss from continuing operations was $7.7 million, or $0.74 per basic and diluted…
Read More »